Chiu Chong-Chi, Lee King-Teh, Wang Jhi-Joung, Sun Ding-Ping, Lee Hao-Hsien, Huang Chien-Cheng, Shi Hon-Yi
Department of General Surgery, Chi Mei Medical Center, Liouying 73657, Taiwan.
Department of General Surgery, Chi Mei Medical Center, Tainan 71004, Taiwan.
J Clin Med. 2019 Apr 27;8(5):576. doi: 10.3390/jcm8050576.
Despite the growing use of minimal clinically important difference (MCID) as a cancer outcome measure, no study has reported clinically significant outcomes in cancer patients. We defined MCID and evaluated the use of preoperative HRQoL for predicting MCID and survival after surgical resection of hepatocellular carcinoma (HCC). In total, 369 patients completed the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and the SF-36 at baseline and at two years post-operative at three tertiary academic hospitals. The corresponding MCID values were 3.6 (SF-36 physical component summary), 4.2 (SF-36 mental component summary), 5.4 (FACT-General total score), and 6.7 (FACT-Hep total score). The predictors of achieving postoperative MCID were significantly higher in patients who had low preoperative HRQoL score, advanced age, high education level, and high BMI ( < 0.05). However, patients with a high preoperative HRQoL score, high education level, high BMI, and low Charlson comorbidity index score were significantly associated with survival ( < 0.05). Preoperative HRQoL scores were predictive of MCID and overall survival after surgical resection of HCC. The findings of this study may be useful for managing the preoperative expectations of candidates for HCC resection and for developing shared decision-making procedures for patients undergoing surgical resection of HCC.
尽管最小临床重要差异(MCID)作为癌症结局指标的应用越来越广泛,但尚无研究报告癌症患者的临床显著结局。我们定义了MCID,并评估了术前健康相关生活质量(HRQoL)对预测肝细胞癌(HCC)手术切除后的MCID和生存情况的作用。在三家三级学术医院中,共有369例患者在基线时以及术后两年完成了癌症治疗-肝胆功能评估(FACT-Hep)和SF-36量表。相应的MCID值分别为3.6(SF-36身体成分总结)、4.2(SF-36心理成分总结)、5.4(FACT-通用总分)和6.7(FACT-Hep总分)。术前HRQoL得分低、年龄大、教育水平高和体重指数(BMI)高的患者实现术后MCID的预测因素显著更高(P<0.05)。然而,术前HRQoL得分高、教育水平高、BMI高和Charlson合并症指数得分低的患者与生存显著相关(P<0.05)。术前HRQoL得分可预测HCC手术切除后的MCID和总体生存情况。本研究结果可能有助于管理HCC切除候选者的术前期望,并为接受HCC手术切除的患者制定共同决策程序。